Life and Death Care, Reflection and Teaching Practice Integrating New Coronavirus Pneumonia Issues

April 7, 2025 updated by: Chang Gung Memorial Hospital

Life and Death Issues in the Post-epidemic Era - Life and Death Care, Reflection and Teaching Practice Integrating New Coronavirus Pneumonia Issues

The basics of life and death are further extended and can meet the life and death needs of clinical care, which is a breakthrough in the existing life and death courses and innovation. The research purposes of this article are (1) to develop a teaching plan for the "Life and Death Issues in the Post-Epidemic Era" course that incorporates the issue of COVID-19; (2) to explore the implementation process and qualitative and quantitative learning effects of "Life and Death Issues in the Post-Epidemic Era"; ( 3) Understand the researcher's reflections on teaching practice through learning reflection and learning effectiveness analysis results. The teaching methods used in this course include: teacher lectures, non-verbal and affective activities with expressive art media, learning by doing and "hands-on", audio-visual teaching, case studies and group discussions, collaborative teaching with teachers, and reflection. The researchers tried to use reflective theory and practice in course teaching, and through reflective writing exercises on issues, cultivate nursing students' understanding of life and death issues, face their own life attitude, death attitude and self-care, and acquire the basic ability of life and death care.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The world has been affected by the coronavirus for more than four years, with more than 400 deaths. Thousands of people die from the epidemic, which is an almost inevitable death issue for medical staff. However, nursing students lack internship experience and do not have enough opportunities to contact dying patients. They are faced with the sudden death of patients due to the outbreak and limited medical equipment. sex, the medical ethical choices that arise, and the impact on society and the medical field. In the past, life and death courses did not specifically discuss life and death issues related to the epidemic. Therefore, integrating current affairs issues related to the new crown epidemic can help us discuss the existing life and death issues. The basics of life and death are further extended and can meet the life and death needs of clinical care, which is a breakthrough in the existing life and death courses and innovation. The research purposes of this article are (1) to develop a teaching plan for the "Life and Death Issues in the Post-Epidemic Era" course that incorporates the issue of COVID-19; (2) to explore the implementation process and qualitative and quantitative learning effects of "Life and Death Issues in the Post-Epidemic Era"; ( 3) Understand the researcher's reflections on teaching practice through learning reflection and learning effectiveness analysis results. The teaching methods used in this course include: teacher lectures, non-verbal and affective activities with expressive art media, learning by doing and "hands-on", audio-visual teaching, case studies and group discussions, collaborative teaching with teachers, and reflection. The researchers tried to use reflective theory and practice in course teaching, and through reflective writing exercises on issues, cultivate nursing students' understanding of life and death issues, face their own life attitude, death attitude and self-care, and acquire the basic ability of life and death care.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Taiwan
      • Tainan, Taiwan, 721
        • Chang Gung Medical Foundation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Students who are willing to participate in this study and have taken courses in life and death

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: life and death care
Life and death issues in the post-epidemic era - Curriculum planning that integrates life and death care, reflective learning and teaching practice on the new coronavirus pneumonia issue, introducing 18-week theme courses, each course is 100 minutes
Other: life and death courses
Life and death issues in the post-epidemic era - Curriculum planning that integrates life and death care, reflective learning and teaching practice on the new coronavirus pneumonia issue, introducing 18-week theme courses, each course is 100 minutes

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Nursing life and death professional knowledge
Time Frame: Tests for the first and eighteenth weeks of the course
Based on the evaluation of end-of-life diseases (top ten non-cancer) and COVID-19's well-being indications and end-of-life symptoms Assessment and care, the grief and needs of dying patients and their families, the cultural, social and psychological significance and functions of funeral rituals, 20 knowledge test questions on funeral culture and religious healing behaviors of various religions and medical ethics and moral dilemmas, etc.
Tests for the first and eighteenth weeks of the course
life attitude scale
Time Frame: Tests for the first and eighteenth weeks of the course
This study used the short version of the Life Attitude Scale to measure students' attitude towards life before and after the course (Xie and Pan, 2015). The scale includes six dimensions, namely: ideals, autonomy, love and care, and sense of existence. , death attitude, life experience, each aspect has four questions, for a total of twenty-four questions. Score on a Likert-7 scale, with 1 representing strongly disagree and 7 representing strongly agree. The higher the score, the more positive the subject's life attitude. The reference for the integrity of this scale (Xie and Pan, 2015) is Cronbach's α value of 0.93. The results of confirmatory factor analysis found that the theoretical model of the study has a good fit, χ²(237) = 1078.58, χ²/df = 4.55, GFI = 0.93, CFI = 0.93, RMSEA = 0.053.
Tests for the first and eighteenth weeks of the course
death attitude scale
Time Frame: Tests for the first and eighteenth weeks of the course
This study used the Death Attitude Scale, using the revised Wong, Reker and Gesser Death Attitude Description Scale. which contains The sub-scale includes death fear (7 questions), death avoidance (5 questions), neutral acceptance (5 questions), approach-oriented death acceptance (10 questions), and escape acceptance (5 questions); death fear refers to the fear of death. and negative thoughts and feelings about dying; death avoidance refers to a defense mechanism that keeps death in the personal subconscious; the concept of neutral acceptance is the degree to which an individual believes that death is neither feared nor expected; approach-oriented death acceptance It refers to the extent to which an individual sees death as a means to a happy afterlife; avoidance acceptance refers to the extent to which an individual sees death as an escape from a painful existence. Score it on a Likert-5 scale, with 1 representing strongly disagree and 5 representing strongly agree.
Tests for the first and eighteenth weeks of the course
Self-compassion scale
Time Frame: Tests for the first and eighteenth weeks of the course
This time we use Lai Zhichao and Su Lunhui (2015) translated as the Chinese version of the Self-Compassion Scale, the revised Chinese version of the scale has 25 items, with a five-point Likert scale, where 1 means almost never, 5 means almost always, and the score The higher the value, the more consistent it is with the item. It contains three aspects and six mutually opposing factors, divided into positive self-care ability (three groups) and negative self-care ability (three groups), namely: self-kindness-self-criticism (a total of 10 questions), shared suffering- Isolated experiences (8 questions in total) and mindfulness-over-identification (7 questions). The Cronbach's α coefficient of the reference Chinese version of the scale is 0.91, and the component reliability of its three scales (self-kindness, shared suffering, and mindfulness) ranges from 0.85 to 0.88. Validity model fit index: CFI value is 0.97, TLI value is 0.96, RMSEA value is 0.06, and SRMR value is 0.06 .
Tests for the first and eighteenth weeks of the course
Spiritual Care Scale
Time Frame: Tests for the first and eighteenth weeks of the course
The original scale was compiled by Lay Hwa Tiew (2012). The spiritual care-giving scale has 35 questions and 4 facets. The first facet is "Characteristics of spiritual care" (No. 22, 23 , 24, 25, 26, 27, 28, 29, 30, 31, 32, 34 and 35 questions); the second aspect "Spirituality and Definition of Spirit" (No. 6, 15, 16, 17, 18, 19 , 20 and 21 items); five items related to the third facet "spiritual perspective" (items 1, 2, 3, 4 and 5) and the fourth facet "spirituality and spiritual care values" (items 7 , 8, 9, 10, 11, 12, 13 and 14 items). It is scored using a six-point method (1-6 points). The higher the score, the higher the Cronbach's a of the four aspects of the original scale. are 0.94, 0.85, 0.84 and 0.86 (Hu et al., 2019). Before using this scale, it is planned to recruit 400 nursing students through snowballing and convenience sampling to establish the reliability and validity of the scale and make revisions.
Tests for the first and eighteenth weeks of the course
Spiritual Health Scale-short version
Time Frame: Tests for the first and eighteenth weeks of the course
There are 24 questions and 5 facets. Each facet is "Connecting with People" (Questions 1 to 4).Questions), "Live with meaning" (Questions 5 to 10), "Beyond adversity" (Questions 11 to 16), "Religious sustenance" (Questions 17 to 20), "Understand one's own mind " (Questions 21 to 24). The Cronbach's a value of the full scale is 0.93. After factor analysis, the Cronbach's a value of each scale ranges from 0.75 to 0.92. The test-retest reliability after three weeks is 0.77 (Xiao and Huang, 2005).
Tests for the first and eighteenth weeks of the course

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Chang Gung Memorial Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
October 15, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 31, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 31, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 7, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 13, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 13, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 202400049B0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings